Form 4: Regina E. Groves Acquires 8,982 Shares of Fulgent Genetics, Inc. (FLGT) as Director

Director Regina E. Groves acquired 8,982 shares of Fulgent Genetics, Inc. on May 15, 2025, through restricted stock units.

Summary

• Regina E. Groves, a director of Fulgent Genetics, Inc., acquired 8,982 shares of common stock on May 15, 2025.
• The acquisition was through restricted stock units (RSUs).
• The price per share was $0.
• Following the transaction, Groves directly owns 16,982 shares of Fulgent Genetics, Inc.
• The RSUs vest over four years, with 1/4th vesting 12 months after May 15, 2025, and 1/16th vesting every three months thereafter, contingent upon continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director, which can be seen as a positive sign of confidence, but it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedule of the restricted stock units indicates a long-term commitment by the director to the company, as continued service is required for the shares to vest.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding insider transactions. They are closely watched by investors to gauge management's sentiment and confidence in the company's performance.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.

Key Dates

Keywords

Fulgent Genetics, FLGT, Regina E. Groves, Director, Stock Acquisition, Restricted Stock Units, Beneficial Ownership, Form 4